| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 658222 | 68313 | EBASTINA VIR 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EBASTINA VIR 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 20 comprimidos | 10 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68313/68313_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68313/68313_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2007-01-08 | 1 | 1 | 1 | 2007-01-08 | 2007-01-08 | 1 | 2016-05-18 | View Edit Delete | ||||||||||||
| 658403 | 68433 | AMLODIPINO VIR 5 mg COMPRIMIDOS EFG | AMLODIPINO VIR 5 mg COMPRIMIDOS EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68433/68433_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68433/68433_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2007-01-30 | 1 | 1 | 1 | 2007-01-30 | 2007-01-30 | 0 | 2011-06-08 | View Edit Delete | ||||||||||||
| 654849 | 06370011 | EXFORGE 5 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE 5 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06370011/06370011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06370011/06370011_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2007-02-08 | 1 | 1 | 1 | 2007-02-08 | 2014-03-17 | 0 | 2013-11-12 | 658408, 663429 | View Edit Delete | |||||||||||
| 654850 | 06370019 | EXFORGE 10 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE 10 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06370019/06370019_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06370019/06370019_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2007-02-08 | 1 | 1 | 1 | 2007-02-08 | 2014-03-17 | 0 | 2013-11-12 | 658409, 663430 | View Edit Delete | |||||||||||
| 654851 | 09569002 | EXFORGE HCT 5 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE HCT 5 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/5 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09569002/09569002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09569002/09569002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2009-12-15 | 1 | 1 | 1 | 2009-12-15 | 2014-03-17 | 0 | 2011-02-24 | 664335 | View Edit Delete | |||||||||||
| 654852 | 09569014 | EXFORGE HCT 10 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE HCT 10 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/10 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09569014/09569014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09569014/09569014_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2009-12-15 | 1 | 1 | 1 | 2009-12-15 | 2014-03-17 | 0 | 2011-02-24 | 664336 | View Edit Delete | |||||||||||
| 654853 | 09569026 | EXFORGE HCT 5 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE HCT 5 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/5 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09569026/09569026_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09569026/09569026_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2009-12-15 | 1 | 1 | 1 | 2009-12-15 | 2014-03-17 | 0 | 2011-02-24 | 664337 | View Edit Delete | |||||||||||
| 654854 | 09569038 | EXFORGE HCT 10 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE HCT 10 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/10 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09569038/09569038_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09569038/09569038_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2009-12-15 | 1 | 1 | 1 | 2009-12-15 | 2014-03-17 | 0 | 2011-02-24 | 664338 | View Edit Delete | |||||||||||
| 655134 | 62024 | VOLTAREN RETARD 75 mg COMPRIMIDOS DE LIBERACION MODIFICADA | VOLTAREN RETARD 75 mg COMPRIMIDOS DE LIBERACION MODIFICADA , 40 comprimidos | 75 mg | 5 | 40 | 10 | 40 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62024/62024_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62024/62024_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 1998-10-01 | 1 | 1 | 1 | 1998-10-01 | 1998-10-01 | 1 | 2011-10-06 | View Edit Delete | ||||||||||||
| 657353 | 62206 | CO-DIOVAN 80 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CO-DIOVAN 80 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos (AL/PVC/PVDC) | 80 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos (AL/PVC/PVDC) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62206/62206_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62206/62206_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 1998-10-01 | 1 | 1 | 1 | 1998-10-01 | 1998-10-01 | 0 | 2011-10-06 | View Edit Delete | ||||||||||||
| 654770 | 71394 | DROGLICAN 200 mg/250 mg CAPSULAS DURAS | DROGLICAN 200 mg/250 mg CAPSULAS DURAS, 90 cápsulas | 200 mg/250 mg | 5 | 90 | 43 | 90 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71394/71394_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71394/71394_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2009-09-25 | 1 | 1 | 1 | 2009-09-25 | 2013-07-08 | 0 | 2013-09-20 | 663933 | View Edit Delete | |||||||||||
| 658358 | 68398 | GRAZAX 75000 SQ-T LIOFILIZADO SUBLINGUAL | GRAZAX 75000 SQ-T LIOFILIZADO SUBLINGUAL, 30 liofilizados | 75.000 SQ-T | 5 | 30 | 10 | 30 liofilizados | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68398/68398_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68398/68398_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | ALK ABELLO S.A. | 2007-01-24 | 1 | 1 | 1 | 2007-01-24 | 2007-01-24 | 1 | 2011-09-08 | View Edit Delete | ||||||||||||
| 654777 | 46584 | ETUMINA 40 MG COMPRIMIDOS | ETUMINA 40 MG COMPRIMIDOS , 30 comprimidos | 40 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/46584/46584_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/46584/46584_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12498 | LABORATOIRES JUVISE PHARMACEUTICALS | 1968-09-01 | 1 | 1 | 1 | 1968-09-01 | 2013-04-10 | 1 | 2013-10-10 | 754143 | View Edit Delete | |||||||||||
| 656124 | 48905 | ALGI-MABO 500 MG CÁPSULAS DURAS | ALGI-MABO 500 MG CÁPSULAS DURAS , 20 cápsulas | 500 mg | 5 | 20 | 43 | 20 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/48905/48905_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/48905/48905_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | MABO FARMA S.A. | 1970-02-01 | 1 | 1 | 1 | 1970-02-01 | 1998-06-01 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 656290 | 68128 | ACIDO ALENDRONICO SEMANAL MABO 70 mg COMPRIMIDOS EFG | ACIDO ALENDRONICO SEMANAL MABO 70 mg COMPRIMIDOS EFG, 4 comprimidos | 70 mg | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68128/68128_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68128/68128_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | MABO FARMA S.A. | 2006-11-02 | 1 | 1 | 1 | 2006-11-02 | 2006-11-02 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 656800 | 68618 | LOSARTAN UXA 50 mg, COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LOSARTAN UXA 50 mg, COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 50 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68618/68618_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68618/68618_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 20478 | UXA FARMA S.A. | 2007-03-28 | 1 | 1 | 1 | 2007-03-28 | 2007-03-28 | 1 | 2011-10-03 | 658768 | View Edit Delete | |||||||||||
| 654757 | 42506 | SUMIAL 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SUMIAL 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 50 comprimidos | 40 mg | 5 | 50 | 10 | 50 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/42506/42506_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/42506/42506_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 35106 | ATNAHS PHARMA NETHERLANDS BV. | 1966-02-01 | 1 | 1 | 1 | 1966-02-01 | 2013-02-07 | 1 | 2014-01-02 | 829176, 672011 | View Edit Delete | |||||||||||
| 654758 | 42504 | SUMIAL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SUMIAL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 50 comprimidos | 10 mg | 5 | 50 | 10 | 50 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/42504/42504_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/42504/42504_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 35106 | ATNAHS PHARMA NETHERLANDS BV. | 1966-02-01 | 1 | 1 | 1 | 1966-02-01 | 2013-02-07 | 1 | 2014-01-02 | 829168, 672012 | View Edit Delete | |||||||||||
| 654846 | 73439 | BALZAK PLUS 40 mg/10 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | BALZAK PLUS 40 mg/10 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 40 mg/10 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73439/73439_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73439/73439_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | LABORATORIOS MENARINI S.A. | 2011-02-21 | 1 | 1 | 1 | 2011-02-21 | 2014-02-03 | 1 | 2014-01-02 | 679051 | View Edit Delete | |||||||||||
| 654847 | 73440 | BALZAK PLUS 40 mg/10 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | BALZAK PLUS 40 mg/10 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg/10 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73440/73440_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73440/73440_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | LABORATORIOS MENARINI S.A. | 2011-02-21 | 1 | 1 | 1 | 2011-02-21 | 2014-02-03 | 1 | 2014-01-02 | 678605 | View Edit Delete |
Page 118 of 1035, showing 20 records out of 20689 total, starting on record 2341, ending on 2360